H-E-B announced today that it has expanded the recall on raw shelled pistachios to include “Fireside Roasted Nut Butter” produced in a limited number of H-E-B stores. The product is being removed because there is potential it could be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.
Dieffenbach’s Potato Chips Inc. Issues Voluntary Recall for Sour Cream & Onion Kettle Chips Due to Possible Salmonella Contamination
Womelsdorf, PA – Dieffenbach’s Potato Chips, Inc. is issuing a voluntary recall for our Sour Cream & Onion Kettle Chips. This decision was made after being informed by a seasoning supplier, that an ingredient in the seasoning may contain traces of salmonella. Although tests have shown no existence of salmonella in the seasoning that was supplied to Dieffenbach’s, out of abundance of caution we are voluntarily issuing the recall of these products in conjunction with FDA guidance.
Read The Complete Story!
Rich Products Corporation Issues Nationwide Allergy Alert on Undeclared Walnuts in Certain Ice Cream Cake Products
Rich Products Corporation in Buffalo, NY, is voluntarily recalling approximately 6,600 cases of ice cream cake products because they may contain undeclared walnuts. People who have an allergy to walnuts run the risk of a serious life threatening allergic reaction if they consume these products.
Read The Complete Story!
FDA permits marketing of new tissue expander for women undergoing breast reconstruction following mastectomy
The U.S. Food and Drug Administration today allowed marketing of a new tissue expander system for soft tissue expansion in two-stage breast reconstruction following mastectomy and in the treatment of underdeveloped breasts and soft tissue deformities. A patient uses a dose controller to independently inflate the expander.
FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions
The U.S. Food and Drug Administration today expanded the approved use of Dexcom’s G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose (sugar) testing for diabetes treatment decisions in people 2 years of age and older with diabetes.
FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions
The U.S. Food and Drug Administration today expanded the approved use of Dexcom’s G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose (sugar) testing for diabetes treatment decisions in people 2 years of age and older with diabetes.
Altijira Murray Products, LLC Recalls Selected Ice Cream Products Because Of Possible Health Risk
Out of an abundance of caution, Altijira Murray Products LLC is undertaking a voluntary recall of selected, 16 oz. (pint size) packages of Foxy’s Thoughtful Ice Cream produced by a contract manufacturer because they have the potential to be contaminated with Listeria monocytogenes.
Read The Complete Story!
Food Recall Warning – Snyder of Berlin Buffalo Blue Kettle Cooked Potato Chips Recalled Due To Possible Salmonella Contamination
Snyder of Berlin is warning consumers not to consume Snyder of Berlin Buffalo Blue Kettle Cooked Potato Chips after being informed by a supplier that a milk powder used within a spice blend ingredient may contain Salmonella.
H-E-B Issues Voluntary Recall On Bakery Products
In cooperation with Dawn Food Products, Inc., H-E-B announced today that it has issued a voluntary recall for certain bakery products made with Valley Milk Products LLC’s High Heat Nonfat Dry Milk Powder. As part of a larger recall affecting several retailers, Valley Milk Products has recalled the affected product, which was supplied to H-E-B for use in bakery products.
Read The Complete Story!
FDA grants accelerated approval to new treatment for advanced ovarian cancer
The U.S. Food and Drug Administration today granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian cancer.